 Connection
Peter Anderson to Tuberculosis
This is a "connection" page, showing publications Peter Anderson has written about Tuberculosis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.371 |
|
|
|
-
Mpofu R, Chandiwana N, Sokhela S, Moorhouse M, Venter F, Anderson PL, Wiesner L, Boffito M, Maartens G, Sinxadi P. The Effect of Rifampicin on the Plasma and Intracellular Pharmacokinetics of Tenofovir Alafenamide Fumarate in HIV-associated Tuberculosis. J Acquir Immune Defic Syndr. 2026 Apr 01; 101(4):424-431.
Score: 0.192
-
Antwi S, Enimil A, Yang H, Martyn-Dickens C, Dompreh A, Amissah AK, Ojewale O, Bosomtwe D, Sly-Moore E, Asiedu P, Frimpong Appiah A, Opoku T, Sarfo AD, Bushman LR, Ellison L, Alghamdi WA, Anderson PL, Kwara A. Pharmacokinetics of Tenofovir Diphosphate, Lamivudine Triphosphate and Emtricitabine Triphosphate in Adolescents With HIV Infection With and Without Tuberculosis Coinfection. Pediatr Infect Dis J. 2025 Apr 10; 44(9):876-881.
Score: 0.179
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|